Q1 2024 Holdings
Filed 2024-05-03 | 10 holdings | $707.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $279.8M | 11,831,461 | 39.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $222.7M | 7,845,364 | 31.5% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $147.1M | 8,677,951 | 20.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $39.8M | 4,866,449 | 5.6% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $15.0M | 2,878,148 | 2.1% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $3.0M | 2,390,050 | 0.4% |